J 2023

Anterior Chamber Iris-Fixated Phakic Intraocular Lens Implantation for Treatment of High Anisometropia in Children: Long-term Results

GRIŠČÍKOVÁ, Lenka, Rudolf AUTRATA, Inka KREJČÍŘOVÁ, Jorge L. ALIÓ, Barbora ŽAJDLÍKOVÁ et. al.

Basic information

Original name

Anterior Chamber Iris-Fixated Phakic Intraocular Lens Implantation for Treatment of High Anisometropia in Children: Long-term Results

Authors

GRIŠČÍKOVÁ, Lenka (703 Slovakia, guarantor, belonging to the institution), Rudolf AUTRATA (203 Czech Republic, belonging to the institution), Inka KREJČÍŘOVÁ (203 Czech Republic, belonging to the institution), Jorge L. ALIÓ, Barbora ŽAJDLÍKOVÁ (203 Czech Republic, belonging to the institution), Dana TOMČÍKOVÁ (203 Czech Republic) and Martin HLOŽÁNEK (203 Czech Republic)

Edition

JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, THOROFARE, SLACK INC, 2023, 0191-3913

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30207 Ophthalmology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 1.200 in 2022

RIV identification code

RIV/00216224:14110/23:00130141

Organization unit

Faculty of Medicine

DOI

UT WoS

000838851100001

Keywords in English

High Anisometropia; Children; Anterior Chamber Iris-Fixated Phakic Intraocular Lens Implantation

Tags

Tags

International impact, Reviewed
Změněno: 26/1/2024 10:35, Mgr. Tereza Miškechová

Abstract

V originále

Purpose: To evaluate the long-term efficacy of anterior chamber iris-fixated phakic intraocular lens (PIOL) implantation in the treatment of high myopic (> -9.00 diopters [D]) or hyperopic (> +6.00 D) anisometropia in children with intolerance to spectacles or contact lenses. Methods: A total of 58 children with anisometropic myopia (range: -9.25 to-18.50 diopters [D]) and 13 children with anisometropic hyperopia (range: +6.00 to +8.50 D) underwent unilateral iris-claw PIOL implantation from 2008 to 2018. The mean age was 6.7 years. The mean follow-up was 38.5 months. Target refraction was emmetropia. Results: The cycloplegic refraction (mean spherical equivalent) improved from -12.47 D (range:-9.25 to-18.50 D) to -0.73 D (range: +0.75 to -1.50 D) in myopic eyes and reduced from +7.15 D (range: +6.00 to +8.50 D) to +0.94 D (range: -0.50 to + 1.75 D) in hyperopic eyes. Eighty-four percent of eyes were corrected to within +/- 1.00 D of emmetropia. The mean uncorrected distance visual acuity (UDVA) improved from 1.74 +/- 0.36 to 0.45 +/- 0.28 logarithm of the minimum angle of resolution (logMAR) (P = .0014). The mean corrected distance visual acuity (CDVA) changed from 0.68 +/- 0.32 to 0.27 +/- 0.15 logMAR (P = .02179). The safety index was 2.18 and the efficacy index was 1.51. The mean preoperative endothelial cell count of 2,874.7 cells/mm(2) changed to 2,685.3 cells/mm(2) at 2 to 6 years postoperatively. Binocular vision quality was improved in 55 patients. No patient had serious complications or lost any Snellen lines of CDVA. Conclusions: Iris-fixated PIOL implantation is an effective and safe method in the treatment of high anisometropic myopia and hyperopia and amblyopia in pediatric patients who are noncompliant with spectacles or contact lenses.